Education
About Us
Working with TipRanks
Follow Us
Nolato AB Class B (SE:NOLA.B)
:NOLA.B
Earnings Data
Report Date
May 06, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.66Last Year’s EPS
0.6Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 07, 2025
|% Change Since: -9.25%
|Next Earnings Date:May 06, 2025
Earnings Call Sentiment|Positive
Despite facing challenges in the Automotive and Pharmaceutical Packaging segments, Nolato demonstrated strong financial performance with increased sales, EBITDA, and growth in key business areas like Medical Solutions and Materials. The company's financial position and strategic contracts further underscore a positive outlook.Company Guidance
During the Q3 2024 earnings call for Nolato, key financial metrics were highlighted, indicating a robust performance. The company reported a 5% increase in sales, reaching SEK 2.4 billion, alongside a notable 22% rise in operating profit, totaling SEK 235 million, which corresponds to an EBITDA margin of 9.8%. The Medical Solutions business area experienced a 5% currency-adjusted growth, with significant contributions from sectors like In Vitro Diagnostics and Drug Delivery. Despite some temporary customer inventory adjustments, particularly in Pharmaceutical Packaging, the quarter ended with total sales of SEK 1,355 million for this segment and an operating profit of SEK 145 million, resulting in a 10.7% margin. Engineered Solutions saw a 4% increase, with standout growth in Materials at 17% after currency adjustments, though the Automotive segment faced challenges. The company's effective tax rate was 21.8%, cash flow from operating activities was a strong SEK 327 million, and net investments rose to SEK 136 million, reflecting ongoing expansion projects. Adjusted earnings per share improved to SEK 0.61, and the return on capital employed climbed to 11.5%. For the full year, CapEx is projected to reach SEK 700 million, largely driven by ongoing projects in Hungary.Increased Sales and EBITDA
Sales increased approximately 5%, with EBITDA rising by 22% to SEK 235 million, resulting in a margin of 9.8%.
Strong Financial Position
The company's financial position is robust, with a relation of EBITDA to financial liabilities at 0.6x, enabling continued global market offerings.
Growth in Medical Solutions
Notable growth in the In Vitro Diagnostics and Drug Delivery segments, with total sales of SEK 1,355 million and a margin of 10.7%.
Engineered Solutions Performance
Currency-adjusted growth of 4% in Engineered Solutions, with significant 17% growth in Materials due to increased volumes.
Improved Group Financial Metrics
Operating profit rose 22% to SEK 235 million, and cash flow from operating activities increased to SEK 327 million.
Positive Customer Contracts in Drug Delivery
The acquisition of a significant customer contract within Drug Delivery validates the company's strategic direction.
---
SE:NOLA.B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SE:NOLA.B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 07, 2025 | kr58.40 | kr61.65 | +5.57% |
| Oct 25, 2024 | kr52.45 | kr55.90 | +6.58% |
| Jul 18, 2024 | kr60.50 | kr59.00 | -2.48% |
| May 06, 2024 | kr53.34 | kr56.55 | +6.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nolato AB Class B (SE:NOLA.B) report earnings?
Nolato AB Class B (SE:NOLA.B) is schdueled to report earning on May 06, 2025, TBA Not Confirmed.
What is Nolato AB Class B (SE:NOLA.B) earnings time?
Nolato AB Class B (SE:NOLA.B) earnings time is at May 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Nolato AB Class B stock?
The P/E ratio of Nolato AB is N/A.
What is SE:NOLA.B EPS forecast?
SE:NOLA.B EPS forecast for the fiscal quarter 2025 (Q1) is 0.66.
---